comparemela.com

Latest Breaking News On - General counsel james herriott - Page 5 : comparemela.com

DekaBank Deutsche Girozentrale Acquires 249 Shares of Exact Sciences Co (NASDAQ:EXAS)

DekaBank Deutsche Girozentrale Acquires 249 Shares of Exact Sciences Co (NASDAQ:EXAS)
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

WoodTrust Financial Corp Sells 250 Shares of Exact Sciences Co (NASDAQ:EXAS)

WoodTrust Financial Corp lessened its holdings in shares of Exact Sciences Co. (NASDAQ:EXAS – Free Report) by 1.6% during the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 15,437 shares of the medical research company’s stock after selling 250 shares during the […]

Exact Sciences (NASDAQ:EXAS) Now Covered by Sanford C Bernstein

Sanford C. Bernstein assumed coverage on shares of Exact Sciences (NASDAQ:EXAS – Free Report) in a research report released on Thursday, MarketBeat reports. The firm issued an outperform rating and a $83.00 price target on the medical research company’s stock. A number of other brokerages also recently issued reports on EXAS. Piper Sandler lifted their […]

Exact Sciences Co (NASDAQ:EXAS) Receives Average Recommendation of Moderate Buy from Brokerages

Shares of Exact Sciences Co. (NASDAQ:EXAS – Get Free Report) have received a consensus recommendation of “Moderate Buy” from the fourteen brokerages that are covering the company, MarketBeat.com reports. Five research analysts have rated the stock with a hold recommendation and nine have issued a buy recommendation on the company. The average 1 year target […]

Exact Sciences Co (NASDAQ:EXAS) is ARK Investment Management LLC s 7th Largest Position

ARK Investment Management LLC lowered its holdings in Exact Sciences Co. (NASDAQ:EXAS – Free Report) by 37.1% during the 2nd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 7,155,098 shares of the medical research company’s stock after selling 4,224,089 shares during the period. […]

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.